Display options
Share it on

Clin Exp Gastroenterol. 2009;2:49-60. doi: 10.2147/ceg.s4778. Epub 2009 Jun 10.

Recent advances in the management of carcinoma of the rectum.

Clinical and experimental gastroenterology

Somprakas Basu, Vivek Srivastava, Vijay K Shukla

Affiliations

  1. Department of General Surgery, Institute of Medical Sciences, Banaras Hindu University, Varanasi, India.

PMID: 21694827 PMCID: PMC3108629 DOI: 10.2147/ceg.s4778

Abstract

In the last two decades rectal cancer has changed from a surgically managed disease into a multidisciplinary treatment model resulting in considerable improvements in the survival and outcome. This has been made possible by better understanding of the tumor biology and oncogenesis, advances in diagnostic and staging investigations, and the changing concepts in surgical excision; from the days of abdominoperineal resection to the concept of "zone of upward spread" and low anterior resection to the era of total mesorectal excision and transanal excision. Efforts are on the way to risk stratification and identification of predictors of nonoperative management. Impressive advances in the adjuvant therapies have seen a sea change in the form of postoperative radiotherapy to preoperative radiotherapy to preoperative chemoradiotherapy and postoperative adjuvant chemotherapy. This multidisciplinary approach is the key to impressive local control rates, decreased metastatic rates, overall survival, and enhancement in quality of life. Newer ideas in the understanding of genetic differences in rectal cancers have stemmed from the observation that these cancers differ in their response to the adjuvant treatment. The present day research has focused these areas of biologic differences in cancers and aims to target the specific loci in malignant cells with monoclonal antibodies directed against various growth factors, key enzyme inhibition, and genetic manipulation. The future research lies in the study of gene expression, micro-array techniques, molecular markers, and better understanding of the predictors of tumor response to therapy.

Keywords: carcinoma of the rectum; chemoradiation; neoadjuvant therapy; recent advances; total mesorectal excision

References

  1. Br J Surg. 2002 Sep;89(9):1142-9 - PubMed
  2. Dis Colon Rectum. 1992 Apr;35(4):362-8 - PubMed
  3. Dis Colon Rectum. 1989 Apr;32(4):307-15 - PubMed
  4. J Clin Oncol. 2004 May 15;22(10):1785-96 - PubMed
  5. J Clin Oncol. 2001 Jan 1;19(1):157-63 - PubMed
  6. J Clin Oncol. 2005 Dec 1;23(34):8697-705 - PubMed
  7. N Engl J Med. 2003 Oct 30;349(18):1774-6; author reply 1774-6 - PubMed
  8. Dis Colon Rectum. 2005 Apr;48(4):711-9; discussion 719-21 - PubMed
  9. Oncologist. 2000;5 Suppl 1:11-5 - PubMed
  10. Arch Pathol Lab Med. 2000 Jul;124(7):979-94 - PubMed
  11. J Natl Cancer Inst. 2001 Apr 18;93(8):583-96 - PubMed
  12. J Clin Oncol. 2005 Nov 20;23(33):8512-9 - PubMed
  13. Radiother Oncol. 1997 Nov;45(2):117-23 - PubMed
  14. N Engl J Med. 2004 Oct 21;351(17):1731-40 - PubMed
  15. J Clin Oncol. 1997 Oct;15(10):3223-9 - PubMed
  16. Arch Surg. 1998 Aug;133(8):894-9 - PubMed
  17. World J Gastroenterol. 2006 May 28;12(20):3186-95 - PubMed
  18. Surg Today. 2005;35(8):629-33 - PubMed
  19. Ann Surg. 1986 Oct;204(4):480-9 - PubMed
  20. Cancer Res. 1993 Oct 1;53(19):4727-35 - PubMed
  21. Br Med Bull. 2002;64:201-25 - PubMed
  22. Clin Oncol (R Coll Radiol). 1995;7(3):188-92 - PubMed
  23. Lancet. 1986 Jun 28;1(8496):1479-82 - PubMed
  24. Cancer Res. 1995 Sep 15;55(18):3964-8 - PubMed
  25. Cancer. 1997 Jul 15;80(2):193-7 - PubMed
  26. Clin Cancer Res. 1998 May;4(5):1243-50 - PubMed
  27. Dig Surg. 2008;25(5):325-7 - PubMed
  28. Cancer Res. 2006 Apr 1;66(7):3370-4 - PubMed
  29. Cancer. 1996 Nov 1;78(9):1871-80 - PubMed
  30. Semin Surg Oncol. 2000 Apr-May;18(3):199-206 - PubMed
  31. J Clin Oncol. 2008 Jan 10;26(2):303-12 - PubMed
  32. Br J Surg. 2007 Oct;94(10):1266-71 - PubMed
  33. Cancer Res. 1998 Nov 1;58(21):4947-56 - PubMed
  34. N Engl J Med. 2001 Apr 19;344(16):1196-206 - PubMed
  35. Clin Cancer Res. 2007 Nov 15;13(22 Pt 2):6913s-20s - PubMed
  36. Ann Surg Oncol. 2001 Dec;8(10):801-6 - PubMed
  37. CA Cancer J Clin. 1971 Nov-Dec;21(6):361-4 - PubMed
  38. J Gastrointest Surg. 2005 Jan;9(1):90-9; discussion 99-101 - PubMed
  39. Cell. 1990 Jun 1;61(5):759-67 - PubMed
  40. Cancer. 1998 Jan 1;82(1):70-7 - PubMed
  41. J Am Coll Surg. 1997 Jun;184(6):584-8 - PubMed
  42. J Nucl Med. 2003 Nov;44(11):1784-8 - PubMed
  43. Dig Surg. 2005;22(1-2):6-15 - PubMed
  44. J Clin Oncol. 2006 Jun 1;24(16):2557-62 - PubMed
  45. Dis Colon Rectum. 1996 Oct;39(10):1140-5 - PubMed
  46. Dis Colon Rectum. 1990 Aug;33(8):654-9 - PubMed
  47. Int J Colorectal Dis. 2002 Nov;17(6):388-95 - PubMed
  48. J Clin Oncol. 2006 Aug 1;24(22):3542-7 - PubMed
  49. Lancet. 1986 Nov 1;2(8514):996-9 - PubMed
  50. J Clin Oncol. 2002 Apr 1;20(7):1744-50 - PubMed
  51. Eur J Surg Oncol. 2002 Sep;28(6):645-51 - PubMed
  52. J Am Coll Surg. 2005 Dec;201(6):948-56 - PubMed
  53. N Engl J Med. 2003 Jul 17;349(3):247-57 - PubMed
  54. J Clin Oncol. 2005 Jun 1;23(16):3706-12 - PubMed
  55. Ann Surg. 1984 Dec;200(6):729-33 - PubMed
  56. Lancet. 2007 Dec 22;370(9605):2112-7 - PubMed
  57. N Engl J Med. 1994 Aug 25;331(8):502-7 - PubMed
  58. Nat Med. 2004 Feb;10(2):145-7 - PubMed
  59. J Clin Oncol. 2005 Dec 1;23(34):8688-96 - PubMed
  60. Clin Adv Hematol Oncol. 2006 Aug;4(8 Suppl 17):1-10; quiz 11-2 - PubMed
  61. Int J Cancer. 1998 Aug 21;79(4):390-5 - PubMed
  62. Radiology. 2004 Sep;232(3):773-83 - PubMed
  63. J Am Coll Surg. 2004 Jul;199(1):1-7 - PubMed
  64. Radiology. 1989 Feb;170(2):319-22 - PubMed
  65. Br J Cancer. 1995 May;71(5):1070-3 - PubMed
  66. J Clin Oncol. 2003 Aug 15;21(16):3098-104 - PubMed
  67. Surg Gynecol Obstet. 1965 May;120:1031-6 - PubMed
  68. J Clin Oncol. 2005 Mar 20;23(9):1826-38 - PubMed
  69. J Am Coll Surg. 1996 Jun;182(6):495-502 - PubMed
  70. Lancet. 2005 May 14-20;365(9472):1718-26 - PubMed
  71. Eur Radiol. 2004 Oct;14 Suppl 8:P25-33 - PubMed
  72. Annu Rev Cell Biol. 1991;7:601-32 - PubMed

Publication Types